Meilleure Health International Industry Group Gestione
Gestione criteri di controllo 4/4
Meilleure Health International Industry Group Il CEO è Wen Chuan Zhou, nominato in Sep2013, e ha un mandato di 11.17 anni. la retribuzione annua totale è HK$ 661.00K, composta da 181.5% di stipendio e -81.5% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.78% delle azioni della società, per un valore di HK$ 8.14M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 8.3 anni e 9.1 anni.
Informazioni chiave
Wen Chuan Zhou
Amministratore delegato
HK$661.0k
Compenso totale
| Percentuale dello stipendio del CEO | 181.5% |
| Mandato del CEO | 11.2yrs |
| Proprietà del CEO | 0.8% |
| Durata media del management | 8.3yrs |
| Durata media del Consiglio di amministrazione | 9.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Meilleure Health International Industry Group's (HKG:2327) Shareholders May Want To Dig Deeper Than Statutory Profit
Oct 04
Earnings Not Telling The Story For Meilleure Health International Industry Group Limited (HKG:2327) After Shares Rise 34%
Sep 05Meilleure Health International Industry Group (HKG:2327) Has A Somewhat Strained Balance Sheet
Aug 30Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk
Jul 19Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around
Jun 17Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking
May 03Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality
Apr 04Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%
Feb 28Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)
Jan 23Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down
Aug 17Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)
Oct 18Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?
Sep 06Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist
Jul 12Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?
Sep 09Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue
May 15Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly
Apr 18Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?
Jan 29
Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay
Dec 08Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | HK$31m |
| Mar 31 2024 | n/a | n/a | HK$36m |
| Dec 31 2023 | HK$661k | HK$1m | HK$41m |
| Sep 30 2023 | n/a | n/a | HK$33m |
| Jun 30 2023 | n/a | n/a | HK$25m |
| Mar 31 2023 | n/a | n/a | HK$22m |
| Dec 31 2022 | HK$987k | HK$1m | HK$18m |
| Sep 30 2022 | n/a | n/a | HK$23m |
| Jun 30 2022 | n/a | n/a | HK$28m |
| Mar 31 2022 | n/a | n/a | HK$44m |
| Dec 31 2021 | HK$2m | HK$1m | HK$60m |
| Sep 30 2021 | n/a | n/a | HK$72m |
| Jun 30 2021 | n/a | n/a | HK$84m |
| Mar 31 2021 | n/a | n/a | HK$84m |
| Dec 31 2020 | HK$2m | HK$1m | HK$83m |
| Sep 30 2020 | n/a | n/a | HK$32m |
| Jun 30 2020 | n/a | n/a | -HK$19m |
| Mar 31 2020 | n/a | n/a | -HK$19m |
| Dec 31 2019 | HK$800k | HK$800k | -HK$20m |
| Sep 30 2019 | n/a | n/a | HK$31m |
| Jun 30 2019 | n/a | n/a | HK$83m |
| Mar 31 2019 | n/a | n/a | HK$82m |
| Dec 31 2018 | HK$540k | HK$540k | HK$81m |
| Sep 30 2018 | n/a | n/a | HK$81m |
| Jun 30 2018 | n/a | n/a | HK$81m |
| Mar 31 2018 | n/a | n/a | HK$81m |
| Dec 31 2017 | HK$540k | HK$540k | HK$80m |
Compensazione vs Mercato: La retribuzione totale di Wen Chuan ($USD 84.93K ) è inferiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 233.02K ).
Compensazione vs guadagni: La retribuzione di Wen Chuan è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Wen Chuan Zhou (41 yo)
11.2yrs
Mandato
HK$661,000
Compensazione
Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of Meilleure Health International Industry Group Limited (formerly known as U-Home Group Holdings Limited) since September 23,...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 11.3yrs | HK$800.00k | 34.4% HK$ 359.0m | |
| Executive Co-Chairman of the Board | 7.1yrs | Nessun dato | 1.83% HK$ 19.1m | |
| Vice Chairman & CEO | 11.2yrs | HK$661.00k | 0.78% HK$ 8.1m | |
| CFO & Company Secretary | 5.3yrs | Nessun dato | Nessun dato | |
| Human Resources Manager | no data | Nessun dato | Nessun dato |
8.3yrs
Durata media
61yo
Età media
Gestione esperta: Il team dirigenziale di 2327 è esperto e expertise (durata media dell'incarico 8.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 11.3yrs | HK$800.00k | 34.4% HK$ 359.0m | |
| Executive Co-Chairman of the Board | 7.1yrs | Nessun dato | 1.83% HK$ 19.1m | |
| Vice Chairman & CEO | 11.3yrs | HK$661.00k | 0.78% HK$ 8.1m | |
| Independent Non-Executive Director | 11.3yrs | HK$180.00k | Nessun dato | |
| Non-Executive Director | 9.1yrs | HK$180.00k | Nessun dato | |
| Independent Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 5.5yrs | HK$120.00k | Nessun dato |
9.1yrs
Durata media
61yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 2327 sono considerati esperti (durata media dell'incarico 9.1 anni).